Fig. 2From: SPON1 is an independent prognostic biomarker for ovarian cancerRepresentative immunohistological images of SPON1 in normal and neoplastic ovarian tissues. Normal ovary and STIC (serous tubal intraepithelial carcinoma) tissues (A), ovarian cancer tissues (B), and ascites-derived tumor cells from ovarian cancer patient (C) were immuno-stained with the anti-SPON1 mAb (clone #1). HE, hematoxylin-eosin. Scale bar, 100 μmBack to article page